MLICM
NUVL

Metropolitan Life Insurance Company (MetLife)’s Nuvalent NUVL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,461
Closed -$110K – 1417
2024
Q1 		$110K Sell
1,461
-25
-2% -$1.99K ﹤0.01% 1001
2023
Q4 		$109K Hold
1,486
– – 0.01% 1029
2023
Q3 		$68.3K Buy
1,486
+161
+12% +$7.15K ﹤0.01% 1220
2023
Q2 		$55.9K Buy
1,325
+246
+23% +$9.3K ﹤0.01% 1361
2023
Q1 		$28.2K Sell
1,079
-207
-16% -$6.12K ﹤0.01% 1716
2022
Q4 		$38.3K Sell
1,286
-232
-15% -$6.47K ﹤0.01% 1633
2022
Q3 		$29.5K Hold
1,518
– – ﹤0.01% 1806
2022
Q2 		$20.6K Hold
1,518
– – ﹤0.01% 2039
2022
Q1 		$21.1K Sell
1,518
-2,147
-59% -$31.2K ﹤0.01% 2069
2021
Q4 		$69.8K Buy
3,665
+360
+11% +$8.02K ﹤0.01% 2640
2021
Q3 		$74.5K Buy
+3,305
New +$95.9K ﹤0.01% 2674

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NUVL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nuvalent (NUVL) in Q2 2024, closing a stake of 1,461 shares — an estimated $110K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NUVL in Q3 2021 and held it in 11 quarters. The position peaked at $110K in Q1 2024. 172 funds tracked by Wall St. Rank hold NUVL as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nuvalent position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,461 Nuvalent shares in Q2 2024, an estimated $110K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nuvalent in Q3 2021 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nuvalent position peaked at $110K in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Nuvalent as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.